{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Liu J"],"funding":["Sanming Project of Medicine in Shen-zhen","Innovative Talent Support Plan of the Medical and Health Technology Project in Zhejiang Province","Ningbo Science and Technology","Ningbo Science and Technology Project","Ningbo Health Branding Subject Fund","National Social Science Foundation"],"pagination":["1108-1119"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7970729"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["36(4)"],"pubmed_abstract":["<h4>Study question</h4>What is the current burden of polycystic ovary syndrome (PCOS) at the global, regional, and country-specific levels in 194 countries and territories according to age and socio-demographic index (SDI)?<h4>Summary answer</h4>Slight increases in age-standardized incidence of PCOS and associated disability-adjusted life-years (DALYs) were evidenced among women of reproductive age (15-49 years) from 2007 to 2017 at the global level, and in most regions and countries.<h4>What is known already</h4>No detailed quantitative estimates of the PCOS incidence and DALYs by age and SDI in these 194 countries and territories have been published previously.<h4>Study design, size, duration</h4>An age- and SDI-stratified systematic analysis of the PCOS incidence and DALYs across 194 co"],"journal":["Human reproduction (Oxford, England)"],"pubmed_title":["Measuring the global disease burden of polycystic ovary syndrome in 194 countries: Global Burden of Disease Study 2017."],"pmcid":["PMC7970729"],"funding_grant_id":["SZSM201803080","PPXK2018-02","19AZD013","202002N3152","2021422878"],"pubmed_authors":["Jiao M","Liu J","Han L","Wu Q","Jiang S","Hao Y","Wang X"],"additional_accession":[]},"is_claimable":false,"name":"Measuring the global disease burden of polycystic ovary syndrome in 194 countries: Global Burden of Disease Study 2017.","description":"<h4>Study question</h4>What is the current burden of polycystic ovary syndrome (PCOS) at the global, regional, and country-specific levels in 194 countries and territories according to age and socio-demographic index (SDI)?<h4>Summary answer</h4>Slight increases in age-standardized incidence of PCOS and associated disability-adjusted life-years (DALYs) were evidenced among women of reproductive age (15-49 years) from 2007 to 2017 at the global level, and in most regions and countries.<h4>What is known already</h4>No detailed quantitative estimates of the PCOS incidence and DALYs by age and SDI in these 194 countries and territories have been published previously.<h4>Study design, size, duration</h4>An age- and SDI-stratified systematic analysis of the PCOS incidence and DALYs across 194 co","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Mar","modification":"2026-05-03T10:10:35.311Z","creation":"2025-04-05T19:13:03.478Z"},"accession":"S-EPMC7970729","cross_references":{"pubmed":["33501984"],"doi":["10.1093/humrep/deaa371"]}}